Further, miR-133b-inhibition significantly attenuate anti-cancer function of si-Lnc MST1P2 both in vitro and in vivo, which verified that Lnc MST1P2 directly targeting miR-133b in CC. The gene discussed is MST1P2; the disease is cancer.